Stocktoria
MASIMO CORP MASI
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2007-08-08
MASIMO CORP financials (annual, from 10-K)
Bars are annual figures from 2016 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $2.0B | $1.2B | $1.1B | $937.8M | $858.3M | $790.2M | $712.9M |
| Gross profit | $945.2M | $794.3M | $765.6M | $1.1B | $808.4M | $743.0M | $629.2M | $574.9M | $522.0M | $478.3M |
| R&D expense | $126.4M | $182.2M | $130.5M | $191.4M | $137.2M | $118.7M | $93.3M | $81.0M | $65.2M | $57.7M |
| SG&A expense | $506.0M | $548.6M | $451.3M | $657.4M | $395.4M | $369.0M | $314.7M | $285.4M | $273.0M | $254.7M |
| Operating income | $310.0M | $63.0M | $166.0M | $210.0M | $275.8M | $255.8M | $221.2M | $208.0M | $183.8M | $435.9M |
| Interest expense | — | — | $50.3M | $25.7M | $300,000 | $300,000 | $328,000 | $706,000 | $678,000 | $3.3M |
| Income tax | $64.9M | $5.6M | $5.3M | $49.9M | $44.8M | $23.4M | $38.0M | $20.2M | $61.0M | $122.4M |
| Net income | -$151.5M | -$304.9M | $81.5M | $143.5M | $229.6M | $240.3M | $196.2M | $193.5M | $124.8M | $311.1M |
| EPS (diluted) | $-2.80 | $-5.60 | $1.51 | $2.60 | $3.98 | $4.14 | $3.44 | $3.45 | $2.23 | $5.85 |
| Operating cash flow | $217.8M | $196.4M | $99.6M | $29.4M | $264.6M | $211.1M | $221.6M | $239.5M | $56.1M | $419.1M |
| Free cash flow | $198.4M | $175.3M | $61.2M | -$23.4M | $239.1M | $138.6M | $153.3M | $222.4M | $12.4M | $399.4M |
| Cash & equivalents | $152.3M | $123.6M | $163.0M | $202.9M | $745.3M | $641.4M | $567.7M | $552.5M | $315.3M | $306.0M |
| Inventory | $380.3M | $294.8M | $545.0M | $501.0M | $201.4M | $216.0M | $115.9M | $94.7M | $92.3M | $72.5M |
| Total assets | $1.7B | $2.6B | $3.0B | $3.2B | $1.9B | $1.7B | $1.4B | $1.2B | $905.4M | $820.5M |
| Total liabilities | $977.7M | $1.6B | $1.7B | $1.9B | $336.8M | $304.9M | $228.3M | $185.8M | $181.4M | $260.3M |
| Shareholders' equity | $721.2M | $1.1B | $1.4B | $1.3B | $1.6B | $1.4B | $1.2B | $969.1M | $724.0M | $584.2M |
Growth · year-over-year · Revenue CAGR 8.8%
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +9.4% | +9.4% | -37.3% | +64.3% | +8.3% | +22.0% | +9.3% | +8.6% | +10.9% | +13.1% |
| Net income growth | — | -474.1% | -43.2% | -37.5% | -4.5% | +22.5% | +1.4% | +55.1% | -59.9% | +273.5% |
| EPS growth | — | -470.9% | -41.9% | -34.7% | -3.9% | +20.3% | -0.3% | +54.7% | -61.9% | +277.4% |
| Free cash flow growth | +13.2% | +186.4% | — | -109.8% | +72.5% | -9.6% | -31.1% | +1696.7% | -96.9% | +497.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000937556 · US · as of 2026-01-03. facts plus Stocktoria's own computed scores — not investment advice.